HIKAL
Back to Income Statement
|
HIKAL Last 5 Year Appropriations History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Appropriations | ₹918 Cr | ₹983 Cr | ₹908 Cr | ₹851 Cr | ₹799 Cr |
What is the latest Appropriations of HIKAL ?
| Year | Appropriations |
|---|---|
| Mar2026 | ₹918 Cr |
| Mar2025 | ₹983 Cr |
| Mar2024 | ₹908 Cr |
| Mar2023 | ₹851 Cr |
| Mar2022 | ₹799 Cr |
How is Appropriations of HIKAL Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2026 | ₹918 Cr | -6.61 | |
| Mar2025 | ₹983 Cr | 8.29 | |
| Mar2024 | ₹908 Cr | 6.66 | |
| Mar2023 | ₹851 Cr | 6.56 | |
| Mar2022 | ₹799 Cr | - | |
Compare Appropriations of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,524.6 Cr | 5.1% | -2.2% | -17.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,991.0 Cr | 1.1% | -4.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹256,310.0 Cr | 7.5% | 1.3% | 45.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,604.0 Cr | 1.8% | -6.3% | 26.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,722.0 Cr | 9.3% | 9.5% | 4.3% | Stock Analytics | |
| CIPLA | ₹109,628.0 Cr | 1.5% | -2.3% | -17.3% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | 5.1% |
-2.2% |
-17.1% |
| SENSEX | 1.2% |
0.4% |
-12.2% |
You may also like the below Video Courses